[Experiencia en la vacunación frente a la COVID-19 en personas con antecedentes de alergia.].

Objective: A common consultation since the beginning of the vaccination campaign against COVID-19 was related to people with a history of allergy to drugs or other vaccines. The objective of the study was to describe what happened after the administration of the vaccine against COVID-19 in people with a history of moderate and severe allergy, vaccinated against COVID-19 in a Primary Care Emergency Center (PCEC).

Methods: Observational descriptive study with sixty-four people with a history of moderate and severe allergy was carried out, vaccinated in PCEP, between May and October 2021, in the Barcelonés Nord and Maresme (Barcelona province), after assessment by primary care pharmacologists and pharmacists.

Antidepressant Drugs and COVID-19: A Review of Basic and Clinical Evidence.

The COVID-19 pandemic has encouraged the repurposing of existing drugs as a shorter development strategy in order to support clinicians with this difficult therapeutic dilemma. There is evidence to support the theory that some antidepressants can reduce concentrations of different cytokines in humans and animals and, recently, the antiviral activity of some antidepressants against SARS-CoV-2 has been reported. The aims of this narrative review are to evaluate the possible role of antidepressants in the treatment of COVID-19 infection and the possible benefits and risks of patients taking antidepressants for mental disorders and COVID-19 infection.

[Quasi-experimental study of an intervention on the pharmacological management of non-oncological chronic pain in Primary Care].

Objective: To analyse the impact of a formative / informative intervention on the treatment of non-oncological chronic pain in Primary Care.

Design: Quasi-experimental study before-after, and follow-up of the patient cohort.

Location: 64 Primary Care teams/centres (770 physicians).

[Adequacy of treatment for osteoporosis in primary prevention. Quantitative and qualitative study].

Objective: Quantitative study: To assess the prevalence of inadequacy of treatment for osteoporosis in primary prevention (OPP) in women aged 60-74years. Qualitative study: To evaluate the diagnostic and treatment criteria of the OPP and it's variability in primary care physicians (PC) and specialists.

Material And Methods: Quantitative study: observational, cross-sectional and retrospective study.